Literature DB >> 21734158

Hepatic arterial stenosis assessed with doppler US after liver transplantation: frequent false-positive diagnoses with tardus parvus waveform and value of adding optimal peak systolic velocity cutoff.

Yang Shin Park1, Kyoung Won Kim, So Jung Lee, Jeongjin Lee, Dong-Hwan Jung, Gi-Won Song, Tae-Yong Ha, Deok-Bog Moon, Ki-Hun Kim, Chul-Soo Ahn, Shin Hwang, Sung-Gyu Lee.   

Abstract

PURPOSE: To evaluate the utility of the tardus parvus waveform of the hepatic artery at Doppler ultrasonography (US) in the diagnosis of hepatic arterial stenosis in liver transplant (LT) recipients and determine whether the accuracy of such a diagnosis is enhanced by including an optimal peak systolic velocity (PSV) cutoff.
MATERIALS AND METHODS: This retrospective study was institutional review board approved; the requirement for informed consent was waived. The authors identified 361 LT recipients (267 male, 94 female) who underwent Doppler US and either computed tomography (CT) or angiography, with an interval between these examinations of less than 1 week. At Doppler US, tardus parvus pattern was defined as a waveform with a resistive index (RI) of less than 0.5 and a systolic acceleration time longer than 0.08 second. At CT or angiography, patients were assigned to the hepatic arterial stenosis (≥50% vessel narrowing) or nonstenosis group. The capability of the tardus parvus pattern to facilitate the diagnosis of hepatic arterial stenosis was calculated. The difference in PSV between the true- and false-positive tardus parvus patterns was evaluated. Receiver operating characteristic (ROC) analysis was performed to determine the optimal cutoff PSV for diagnosing hepatic arterial stenosis. The capability of the tardus parvus pattern and an optimal PSV cutoff in the diagnosis of hepatic arterial stenosis was determined.
RESULTS: Sixty transplant recipients had the tardus parvus pattern at Doppler US. The sensitivity, specificity, and positive predictive value (PPV) of the tardus parvus pattern were 72% (23 of 32 LT recipients), 88.8% (292 of 329 LT recipients), and 38% (23 of 60 LT recipients), respectively. The false-positive rate was 11.2% (37 of 329 LT recipients). ROC analysis revealed an optimal PSV cutoff of less than or equal to 48 cm/sec for diagnosing hepatic arterial stenosis. The combination of the tardus parvus pattern and a PSV cutoff of less than or equal to 48 cm/sec improved specificity to 99.1% (326 of 329 LT recipients) and the PPV to 88% (22 of 25 LT recipients), thereby reducing the false-positive rate to 1% (three of 329 LT recipients) while slightly decreasing the sensitivity to 69% (22 of 32 LT recipients).
CONCLUSION: Use of the tardus parvus waveform of the hepatic artery resulted in a low PPV and a high false-positive rate. However, the combination of the tardus parvus pattern and an optimal PSV cutoff greatly improved the PPV and reduced the false-positive rate in the diagnosis of hepatic arterial stenosis.

Entities:  

Mesh:

Year:  2011        PMID: 21734158     DOI: 10.1148/radiol.11102257

Source DB:  PubMed          Journal:  Radiology        ISSN: 0033-8419            Impact factor:   11.105


  19 in total

Review 1.  Vascular complications after adult living donor liver transplantation: Evaluation with ultrasonography.

Authors:  Lin Ma; Qiang Lu; Yan Luo
Journal:  World J Gastroenterol       Date:  2016-01-28       Impact factor: 5.742

2.  Hepatic artery reconstruction in living donor liver transplantation: risk factor analysis of complication and a role of MDCT scan for detecting anastomotic stricture.

Authors:  Shigeru Marubashi; Shogo Kobayashi; Hiroshi Wada; Koichi Kawamoto; Hidetoshi Eguchi; Yuichiro Doki; Masaki Mori; Hiroaki Nagano
Journal:  World J Surg       Date:  2013-11       Impact factor: 3.352

3.  The effect of Doppler ultrasound on early vascular interventions and clinical outcomes after liver transplantation.

Authors:  Hannah Lee; Chae-Won Lim; Seok Ha Yoo; Chang-Hoon Koo; Woo-Il Kwon; Kyung-Suk Suh; Ho Geol Ryu
Journal:  World J Surg       Date:  2014-12       Impact factor: 3.352

Review 4.  Doppler ultrasonography in living donor liver transplantation recipients: Intra- and post-operative vascular complications.

Authors:  Omar Abdelaziz; Hussein Attia
Journal:  World J Gastroenterol       Date:  2016-07-21       Impact factor: 5.742

5.  Is Routine Intraoperative Contrast-Enhanced Ultrasonography Useful During Whole Liver Transplantation?

Authors:  Nicolas Golse; Simone Santoni; Vincent Karam; Oriana Ciacio; Gabriella Pittau; Marc-Antoine Allard; Daniel Cherqui; Antonio Sa Cunha; René Adam; Denis Castaing; Eric Vibert
Journal:  World J Surg       Date:  2018-05       Impact factor: 3.352

6.  Doppler ultrasonography in liver transplant recipients with hepatic artery dissection: association of Doppler abnormalities with disease severity.

Authors:  So Yeong Jeong; Kyoung Won Kim; Jin Sil Kim; Sunyoung Lee; So Yeon Kim; Gi Won Song; Sung Gyu Lee
Journal:  Br J Radiol       Date:  2018-05-23       Impact factor: 3.039

Review 7.  Post-operative imaging in liver transplantation: state-of-the-art and future perspectives.

Authors:  Rossano Girometti; Giuseppe Como; Massimo Bazzocchi; Chiara Zuiani
Journal:  World J Gastroenterol       Date:  2014-05-28       Impact factor: 5.742

8.  Management and Outcome of Liver Abscesses After Liver Transplantation.

Authors:  Iago Justo; Carlos Jiménez-Romero; Alejandro Manrique; Oscar Caso; Jorge Calvo; Felix Cambra; Alberto Marcacuzco
Journal:  World J Surg       Date:  2018-10       Impact factor: 3.352

9.  Liver transplantation: fifty years of experience.

Authors:  Alice Tung Wan Song; Vivian Iida Avelino-Silva; Rafael Antonio Arruda Pecora; Vincenzo Pugliese; Luiz Augusto Carneiro D'Albuquerque; Edson Abdala
Journal:  World J Gastroenterol       Date:  2014-05-14       Impact factor: 5.742

10.  Computer-assisted detection of tardus parvus waveforms on Doppler ultrasound.

Authors:  Gowthaman Gunabushanam; John D Millet; Erik Stilp; Forrest W Crawford; Robert L McNamara; Leslie M Scoutt
Journal:  Ultrasound       Date:  2017-12-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.